文献速递其他结缔组织病

抗纤维化因子KLF4在皮肤成纤维细胞中被miR-10/TFAP2A/TBX5轴抑制:来自系统性硬化症不一致双胞胎的启示

Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis.
PubMed 文献 · Ann Rheum Dis · 2021-11-08

研究对系统性硬化症(SSc)不一致双胞胎的皮肤成纤维细胞(dFBs)进行全基因表达和全基因组DNA甲基化分析,发现KLF4、TBX5、TFAP2A等转录因子及miR-10a、miR-10b差异表达和甲基化。SSc dFBs中KLF4表达降低,并被TBX5和TFAP2A抑制;KLF4具抗纤维化作用,其条件性敲除促进纤维化表型。结论支持表观遗传失调在SSc易感性中的作用,并提示表观遗传修饰剂未来治疗潜力。

要点

  • SSc不一致双胞胎dFBs中KLF4、TBX5、TFAP2A及同源框基因差异表达和甲基化。
  • SSc dFBs中KLF4表达降低,且被TBX5和TFAP2A抑制。
  • KLF4具抗纤维化作用,成纤维细胞条件性敲除促进纤维化表型。

核心结论

  • 数据支持dFBs中表观遗传失调介导SSc易感性,揭示CpG甲基化、miRNA和转录因子在SSc发病中的复杂相互作用,并强调表观遗传修饰剂未来治疗潜力。

研究设计与样本

  • 对SSc不一致双胞胎队列的皮肤成纤维细胞进行全基因表达和全基因组DNA甲基化分析,并用体外、离体和体内模型验证。

主要发现

  • 发现差异表达和甲基化基因,包括参与干细胞分化和发育程序的转录因子KLF4、TBX5、TFAP2A和同源框基因,以及靶向部分失调基因的miR-10a和miR-10b。
  • SSc dFBs中KLF4表达降低,且其表达被TBX5和TFAP2A抑制。
  • KLF4具抗纤维化作用,成纤维细胞条件性敲除促进纤维化表型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic sclerosis (SSc) is a complex disease of unknown aetiology in which inflammation and fibrosis lead to multiple organ damage. There is currently no effective therapy that can halt the progression of fibrosis or reverse it, thus studies that provide novel insights into disease pathogenesis and identify novel potential therapeutic targets are critically needed. METHODS: We used global gene expression and genome-wide DNA methylation analyses of dermal fibroblasts (dFBs) from a unique cohort of twins discordant for SSc to identify molecular features of this pathology. We validated the findings using in vitro, ex vivo and in vivo models. RESULTS: Our results revealed distinct differentially expressed and methylated genes, including several transcription factors involved in stem cell differentiation and developmental programmes (KLF4, TBX5, TFAP2A and homeobox genes) and the microRNAs miR-10a and miR-10b which target several of these deregulated genes. We show that KLF4 expression is reduced in SSc dFBs and its expression is repressed by TBX5 and TFAP2A. We also show that KLF4 is antifibrotic, and its conditional knockout in fibroblasts promotes a fibrotic phenotype. CONCLUSIONS: Our data support a role for epigenetic dysregulation in mediating SSc susceptibility in dFBs, illustrating the intricate interplay between CpG methylation, miRNAs and transcription factors in SSc pathogenesis, and highlighting the potential for future use of epigenetic modifiers as therapies.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Malaab M, Renaud L, Takamura N, et al. Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. Ann Rheum Dis. 2021. PMID: 34750102. doi:10.1136/annrheumdis-2021-221050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。